Calculation
| P/OP | = | Share price1, 2, 3 | ÷ | Operating profit per share1 | Operating profit per share1 | = | Earnings from operations1 (in millions) |
÷ | No. shares of common stock outstanding2 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 2, 2026 | 14.12 | = | 294.93 | ÷ | 20.89 | 20.89 | = | 18,964 | ÷ | 907,675,839 | |
| Feb 27, 2025 | 13.27 | = | 468.56 | ÷ | 35.30 | 35.30 | = | 32,287 | ÷ | 914,712,333 | |
| Feb 28, 2024 | 14.20 | = | 498.28 | ÷ | 35.10 | 35.10 | = | 32,358 | ÷ | 921,934,109 | |
| Feb 24, 2023 | 15.89 | = | 484.33 | ÷ | 30.48 | 30.48 | = | 28,435 | ÷ | 932,846,602 | |
| Feb 15, 2022 | 18.77 | = | 478.23 | ÷ | 25.48 | 25.48 | = | 23,970 | ÷ | 940,899,146 | |
| Mar 1, 2021 | 14.12 | = | 334.65 | ÷ | 23.70 | 23.70 | = | 22,405 | ÷ | 945,319,404 | |
| Feb 14, 2020 | 14.40 | = | 298.78 | ÷ | 20.75 | 20.75 | = | 19,685 | ÷ | 948,573,372 | |
| Feb 12, 2019 | 14.58 | = | 263.50 | ÷ | 18.08 | 18.08 | = | 17,344 | ÷ | 959,538,515 | |
| Feb 13, 2018 | 14.42 | = | 226.64 | ÷ | 15.72 | 15.72 | = | 15,209 | ÷ | 967,662,919 | |
| Feb 8, 2017 | 11.79 | = | 160.31 | ÷ | 13.59 | 13.59 | = | 12,930 | ÷ | 951,165,192 | |
| Feb 9, 2016 | 9.59 | = | 111.16 | ÷ | 11.59 | 11.59 | = | 11,021 | ÷ | 950,673,998 | |
| Feb 10, 2015 | 10.12 | = | 108.97 | ÷ | 10.77 | 10.77 | = | 10,274 | ÷ | 953,695,161 | |
| Feb 12, 2014 | 7.22 | = | 70.24 | ÷ | 9.73 | 9.73 | = | 9,623 | ÷ | 989,191,844 | |
| Feb 7, 2013 | 6.32 | = | 57.05 | ÷ | 9.03 | 9.03 | = | 9,254 | ÷ | 1,024,925,324 | |
| Feb 9, 2012 | 6.55 | = | 53.06 | ÷ | 8.10 | 8.10 | = | 8,464 | ÷ | 1,044,964,149 | |
| Feb 10, 2011 | 5.90 | = | 42.43 | ÷ | 7.19 | 7.19 | = | 7,864 | ÷ | 1,093,694,629 | |
| Feb 10, 2010 | 5.95 | = | 32.71 | ÷ | 5.49 | 5.49 | = | 6,359 | ÷ | 1,157,533,379 | |
| Feb 11, 2009 | 6.59 | = | 28.55 | ÷ | 4.33 | 4.33 | = | 5,263 | ÷ | 1,215,615,705 | |
| Feb 21, 2008 | 7.62 | = | 47.80 | ÷ | 6.27 | 6.27 | = | 7,849 | ÷ | 1,251,382,699 | |
| Mar 6, 2007 | 10.47 | = | 53.98 | ÷ | 5.16 | 5.16 | = | 6,984 | ÷ | 1,354,320,209 | |
| Feb 24, 2006 | 14.87 | = | 58.89 | ÷ | 3.96 | 3.96 | = | 5,373 | ÷ | 1,356,292,073 |
Based on: 10-K (reporting date: 2025-12-31), 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).
1 US$
2 Data adjusted for splits and stock dividends.
3 Closing price as at the filing date of UnitedHealth Group Inc. Annual Report.
The Price to Operating Profit (P/OP) ratio for the period examined exhibits considerable fluctuation, though generally trends upward over the long term. Initial values indicate a relatively high ratio, followed by a period of decline, stabilization, and subsequent increase. A detailed examination reveals distinct phases in the ratio’s behavior.
- Initial Decline (2006-2008)
- From 2006 to 2008, the P/OP ratio decreased from 14.87 to 7.62. This decline coincided with a period of decreasing share price and increasing operating profit per share, suggesting that while earnings were improving, investor valuation did not keep pace, or perhaps decreased at a faster rate.
- Stabilization and Moderate Growth (2009-2014)
- Between 2009 and 2014, the P/OP ratio demonstrated a period of relative stability, fluctuating between approximately 5.95 and 10.12. While some variation occurred, the ratio remained within a constrained range, indicating a balance between share price and operating profit per share growth. A slight upward trend is observable during this period.
- Significant Increase (2015-2018)
- From 2015 to 2018, the P/OP ratio experienced a notable increase, rising from 9.59 to 14.42. This increase was driven by a substantial rise in share price, outpacing the growth in operating profit per share. This suggests increasing investor confidence and a willingness to pay a higher premium for each dollar of operating profit.
- Peak and Subsequent Decline (2019-2023)
- The ratio peaked in 2019 at 14.58, remaining relatively stable through 2020 and 2021. However, from 2022 to 2023, a decline is observed, moving from 18.77 to 14.20. This decrease is attributable to a combination of share price decline and increasing operating profit per share.
- Recent Volatility (2024-2026)
- The most recent period (2024-2026) shows significant volatility. The P/OP ratio decreased sharply in 2024 to 13.27, then experienced a substantial drop to 14.12 in 2026. This suggests a recent shift in market perception or underlying business conditions impacting valuation. The operating profit per share also decreased during this period.
Overall, the P/OP ratio demonstrates a complex pattern influenced by both share price and operating profit per share. The ratio’s fluctuations suggest changing investor sentiment and evolving market conditions. The recent volatility warrants further investigation to determine the underlying causes and potential implications for future performance.
AI Ask an analyst for more
Comparison to Competitors
| UnitedHealth Group Inc. | Abbott Laboratories | Intuitive Surgical Inc. | Medtronic PLC | |
|---|---|---|---|---|
| Mar 2, 2026 | 14.12 | 24.21 | 57.74 | 18.58 |
| Feb 27, 2025 | 13.27 | 34.28 | 86.83 | 19.98 |
| Feb 28, 2024 | 14.20 | 30.54 | 75.42 | 21.20 |
| Feb 24, 2023 | 15.89 | 22.18 | 54.49 | 20.48 |
| Feb 15, 2022 | 18.77 | 24.45 | 56.11 | 37.44 |
| Mar 1, 2021 | 14.12 | 40.69 | 88.37 | 26.29 |
| Feb 14, 2020 | 14.40 | 34.03 | 48.89 | 21.26 |
| Feb 12, 2019 | 14.58 | 36.64 | 49.87 | 17.64 |
| Feb 13, 2018 | 14.42 | 60.88 | 44.40 | 22.64 |
| Feb 8, 2017 | 11.79 | 24.25 | 28.93 | 22.18 |
| Feb 9, 2016 | 9.59 | 19.80 | 27.25 | 28.81 |
| Feb 10, 2015 | 10.12 | 27.50 | 34.42 | 16.68 |
| Feb 12, 2014 | 7.22 | 22.79 | 17.96 | 11.80 |
| Feb 7, 2013 | 6.32 | 6.82 | 26.21 | — |
| Feb 9, 2012 | 6.55 | 15.35 | 27.83 | — |
| Feb 10, 2011 | 5.90 | 11.92 | 23.28 | — |
| Feb 10, 2010 | 5.95 | 13.54 | 33.47 | — |
| Feb 11, 2009 | 6.59 | 14.66 | 14.45 | — |
| Feb 21, 2008 | 7.62 | 18.76 | 55.84 | — |
| Mar 6, 2007 | 10.47 | 40.49 | 38.98 | — |
| Feb 24, 2006 | 14.87 | 15.48 | 50.21 | — |
Based on: 10-K (reporting date: 2025-12-31), 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).